METASTATIC COLON CANCER
Clinical trials for METASTATIC COLON CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC COLON CANCER trials appear
Sign up with your email to follow new studies for METASTATIC COLON CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for hard-to-treat colon cancer? trial tests ompenaclid combo
Disease control TerminatedThis study tested whether adding the experimental drug ompenaclid to standard chemotherapy could shrink tumors in people with advanced colorectal cancer that has a RAS mutation. About 76 participants were randomly assigned to receive either ompenaclid or a placebo, along with the…
Matched conditions: METASTATIC COLON CANCER
Phase: PHASE2 • Sponsor: Inspirna, Inc. • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
Turmeric compound tested against resistant colon cancer
Disease control TerminatedThis early study tested whether adding curcumin (a compound found in turmeric) to a standard chemotherapy drug could be safe and help people with advanced colon cancer that no longer responds to treatment. The study planned to enroll 15 adults with metastatic colon cancer. The go…
Matched conditions: METASTATIC COLON CANCER
Phase: EARLY_PHASE1 • Sponsor: Baylor Research Institute • Aim: Disease control
Last updated May 19, 2026 11:47 UTC